InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by Rosenberg Noah L., Directeur Médical. Insider active across 1 companies, notably Travere Therapeutics, Inc.. Cumulatively, 6 filings have been logged. Total volume traded: €41k. The latest transaction was filed on 13 August 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations6 total
04,500 shares0
Common Stock
SEC:0001209191-21-052083·
04,500 shares0
Common Stock
SEC:0001209191-21-052083:0·
€14,5721,250 shares@ €11.6580.0004% mcap71.1% of flow
Common Stock
SEC:0001209191-21-048494·
€14,5721,250 shares@ €11.6580.0004% mcap35.6% of flow
Common Stock
SEC:0001209191-21-048494:0·
€5,910375 shares@ €15.76020.0001% mcap28.9% of flow
Common Stock
SEC:0001209191-21-032319·
€5,910375 shares@ €15.76020.0001% mcap14.4% of flow
Common Stock
SEC:0001209191-21-032319:0·
6 of 6 declarations
About Rosenberg Noah L.
Noah L. Rosenberg is the Chief Medical Officer at Travere Therapeutics, Inc. He is responsible for medical strategy and clinical research. His expertise in medicine and drug development is essential for guiding the company's research initiatives.
